---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-25-000022"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:13:11.438044+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pacira BioSciences appoints Laura Brege as Board Chair; two directors retire

## Summary
- Paul J. Hastings (former Chair) and Andreas Wicki retired effective Jan. 28, 2025; no disagreement cited.
- Laura Brege appointed Chair; brings 30 years pharma/biotech executive experience.
- Board reduced from 12 to 9 directors; 8 of 9 are independent; 5 joined since Oct. 2023.
- Alethia Young succeeds Brege as Audit Committee Chair; other committee assignments refreshed.
- Brege previously held leadership roles at BridgeBio, Onyx Pharmaceuticals, and COR Therapeutics.

## SEC filing metadata
- accession: 0001396814-25-000022
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/pcrx-20250128.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-25-000022
- JSON: https://secwatch.observer/filing/0001396814-25-000022.json
- Plain text: https://secwatch.observer/filing/0001396814-25-000022.txt

## Key facts
- Executive change
  Paul J. Hastings resigned as Chair of the Board at Pacira BioSciences, Inc..
  - Action: resigned
  - Role: Chair of the Board
  source text: On January 28, 2025, Paul J. Hastings, Chair of the Board of Directors (the “Board”), and Andreas Wicki, a member of the Board, each notified the Board of Pacira BioSciences, Inc. (the “Company”) of his respective decision to resign as a member of the Board, in each case, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm
- Executive change
  Andreas Wicki resigned as Member of the Board at Pacira BioSciences, Inc..
  - Action: resigned
  - Role: Member of the Board
  source text: On January 28, 2025, Paul J. Hastings, Chair of the Board of Directors (the “Board”), and Andreas Wicki, a member of the Board, each notified the Board of Pacira BioSciences, Inc. (the “Company”) of his respective decision to resign as a member of the Board, in each case, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm
- Executive change
  Laura Brege was appointed as Chair of the Board at Pacira BioSciences, Inc..
  - Action: appointed
  - Role: Chair of the Board
  source text: the Board, upon recommendation of the Nominating, Governance and Sustainability Committee of the Board, appointed Laura Brege as Chair of the Board, effective as of immediately following the effectiveness of the Resignations.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000139681425000022/0001396814-25-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.